Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06546696 · ClinicalTrials.gov registry record · NA

The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings

A NA study of Childhood Obesity, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
750
Enrollment target
1
Study location

NCT06546696: Recruiting NA study of Childhood Obesity, sponsored by Vanderbilt University Medical Center.

NCT06546696 is a NA study of Childhood Obesity that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 750 participants, above the 543-participant average among 43 other Childhood Obesity trials with a reported enrollment target (38% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06546696, a NA study of Childhood Obesity, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
750 participants
Enrollment target
1
Study location

Study Summary

Evidence-based obesity treatment is inaccessible to most children in the United States. This lack of access is a source of health inequity, whereby children from rural and minority communities, who have the highest rates of childhood obesity, are also the least likely to receive an evidence-based intervention. Developing strategies to improve access to evidence-based obesity interventions could reduce health disparities by improving reach to these underserved communities. The premise of this study is that using a systematic framework to adapt a community-based behavioral intervention for childhood obesity that accounts for individual, family, and community factors will increase reach and effectiveness among low-income, minority, and rural populations. COACH is a multi-level obesity intervention that supports 1) the individual child through developmentally appropriate health behavior curriculum, 2) the family by directly addressing parent weight loss and engaging parents as agents of change for their children, and 3) the community by building the capacity of local community centers to offer parent-child programming. The investigators propose testing the process of adapting COACH in a cluster-randomized trial.

Primary Outcome

Calculated from CDC growth curves

Conditions Studied

Interventions

  • BEHAVIORAL Competency Based Approaches to Community Health (COACH)

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2024-10-23
Est. Completion 2028-12-01
Phase NA

What NCT06546696 shows while recruiting

NCT06546696 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 543-participant average among 43 other Childhood Obesity trials with a reported enrollment target (38% higher).

The record links to 1 condition, with Childhood Obesity appearing as the primary indexed condition, and to 1 intervention - of which Competency Based Approaches to Community Health (COACH) is the first listed.

NCT06546696 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06546696 about?

NCT06546696 is a clinical study titled "The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings". Evidence-based obesity treatment is inaccessible to most children in the United States. This lack of access is a source of health inequity, whereby children from rural and minority communities, who have the highest rates of childhood obesity, are also the least likely to receive an evidence-based in...

What is the current status of trial NCT06546696?

This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2024-10-23. Estimated completion is 2028-12-01.

What conditions does trial NCT06546696 study?

This clinical trial studies the following conditions: Childhood Obesity.

What interventions are being tested in trial NCT06546696?

The interventions under investigation include: Competency Based Approaches to Community Health (COACH) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06546696?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06546696 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06546696's enrollment target sits among peer trials

750 9th of 43 higher than 35 of 43 other Childhood Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02048332 · 750 participants · Phase 1

    Donor-Derived Viral Specific T-cells (VSTs)

  • NCT02087852 · 750 participants

    Kidney Cancer DNA Registry

  • NCT02532452 · 750 participants · Phase 2

    Third Party Viral Specific T-cells (VSTs)

  • NCT03126916 · 750 participants · Phase 3

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06546696, the US trial registry maintained by the National Library of Medicine. NCT06546696 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.